BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1222 related articles for article (PubMed ID: 25987261)

  • 1. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum.
    Audard V; Georges B; Vanhille P; Toly C; Deroure B; Fakhouri F; Cuvelier R; Belenfant X; Surin B; Aucouturier P; Mougenot B; Ronco P
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1339-49. PubMed ID: 18632851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
    Higgins L; Nasr SH; Said SM; Kapoor P; Dingli D; King RL; Rajkumar SV; Kyle RA; Kourelis T; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Ansell SM; Gonsalves WI; Thompson CA; Fervenza FC; Zand L; Hwa YL; Jevremovic D; Shi M; Leung N
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1037-1046. PubMed ID: 29848505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
    Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
    Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis with IgM monoclonal gammopathies.
    Gertz MA; Kyle RA
    Semin Oncol; 2003 Apr; 30(2):325-8. PubMed ID: 12720162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
    Gertz MA; Kyle RA; Noel P
    J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.
    Tan SYS; Sibley RK; Belani S; Iwasaki S; Yankulin L; Jonelis T; Higgins JPT; Kambham N; Troxell ML
    J Nephrol; 2018 Dec; 31(6):907-918. PubMed ID: 30334170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
    Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
    Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
    Nie G; Sun L; Zhang C; Yuan Y; Mao H; Wang Z; Li J; Duan S; Xing C; Zhang B
    Front Immunol; 2022; 13():903315. PubMed ID: 36172352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
    Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
    Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.
    Liu J; Liang D; Liang S; Xu F; Huang X; Jiang S; Hou J
    Sci Rep; 2022 Oct; 12(1):16994. PubMed ID: 36216844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy: significance and possible causality in renal disease.
    Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
    Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
    Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
    Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.
    Guiard E; Karras A; Plaisier E; Duong Van Huyen JP; Fakhouri F; Rougier JP; Noel LH; Callard P; Delahousse M; Ronco P
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1609-16. PubMed ID: 21700823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous occurrence of fibrillary glomerulonephritis and renal lesions in nonmalignant monoclonal IgM gammopathy.
    Wu CK; Leu JG; Yang AH; Tarng DC; Tung HY; Chiang SS
    BMC Nephrol; 2016 Feb; 17():17. PubMed ID: 26892336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders.
    Javaugue V; Debiais-Delpech C; Nouvier M; Gand E; Chauvet S; Ecotiere L; Desport E; Goujon JM; Delwail V; Guidez S; Tomowiak C; Leleu X; Jaccard A; Rioux-Leclerc N; Vigneau C; Fermand JP; Touchard G; Thierry A; Bridoux F
    Kidney Int; 2019 Jul; 96(1):94-103. PubMed ID: 30987838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
    Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
    Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.